Morgan Primary Health Care
What is GeneSight® testing?
GeneSight® Psychotropic is a pharmacogenomic test which means that it analyzes how genes may affect medication outcomes. A GeneSight® test analyzes clinically important genetic variations in DNA. Results can inform clinicians about how certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions may be broke down or responded to.
A GeneSight® test must be ordered by medical provider. The test is a simple cheek swab taken in the health care provider’s office.
If you think genetic testing could be helpful, Request an Appointment to discuss a GeneSight® Psychotropic test.
How does GeneSight® work?
GeneSight® analyzes genes involved in pharmacokinetics and pharmacodynamics to weigh their combined influence on patient response to psychotropic medications. This combinatorial approach used only by GeneSight® has been demonstrated to drive improved patient outcomes in multiple clinical studies.
GeneSight® guides prescribing clinicians by placing each medication into one of three color-coded categories: “Use as Directed” in green, “Moderate Gene-Drug Interaction” in yellow, or “Significant Gene-Drug Interaction” in red. This categorization enables physicians to select genetically appropriate medications for each patient, increasing the likelihood of response and reducing the risk of adverse events.
If you think genetic testing could be helpful for you, Request an Appointment to discuss the GeneSight® Psychotropic test.
It’s time to finally feel like yourself again.
If you are struggling with medications for mental health conditions like depression, anxiety, or ADHD, you are not alone. We know the process of finding medication that works can be frustrating, time-consuming and debilitating.
Fewer than 50% of individuals with depression respond to their first medication.
1 in 6 Americans develop major depressive disorder in their lifetime. Medications serve as the primary course of care for this condition, yet fewer than half of all depressed patients respond well to their first prescription and overall treatment failure rates exceed 50%.
This high failure rate is compounded by the fact that six weeks are typically necessary to observe the effectiveness of MDD medications, a timeline aggravated by the common approach of starting patients on low doses and making gradual increases in order to avoid significant side effects. Patients also become less responsive and less adherent with each subsequent medication, and the likelihood of an adverse event increases.
Why take a GeneSight® test?
If you have been diagnosed with a mental health condition and failed at least one medication, consider talking to your primary health care provider about the GeneSight® Psychotropic test. GeneSight® Psychotropic is a pharmacogenomic test that analyzes clinically important genetic variations in your DNA.
The results of the test can inform your medical provider about genes that may impact how you metabolize or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other mental health conditions.
Single Diagnostic Test – $330.00 (on average)
Most people are able to use insurance with this test.